Their signs may include difficulty breathing, swelling of the face or neck, severe pain, vomiting, fever, and yellowing of the skin or eyes [25]
,
doi: 10.1089/thy.2009.1607 2 ParkYJAhnHYChoiHSKimKWParkDJChoBY
GLP-1 Receptor Agonist Market The GLP-1 receptor agonist market is segmented by Drug (Semaglutide, Exenatide, Lixisenatide, Liraglutide, Dulaglutide, and Others), by Route of Administration (Oral and Parenteral), by Indication (Diabetes, Obesity, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region
Beecher, G., Anderson, D
7 The global rollout of these medications will be determined by their affordability and the efficiency of production processes